Literature DB >> 9271027

Two case reports of breast carcinoma associated with prolactinoma.

I Strungs1, R A Gray, H B Rigby, G Strutton.   

Abstract

Two cases of breast carcinoma associated with prolactinoma are presented. Literature review reveals only five previous case reports of this association. Both of our cases occurred in women, aged 55 and 34. Both were typical of the reported cases in that they had long histories of amenorrhea before diagnosis of prolactinomas and breast carcinomas. One patient had a three and a half year history of atypical ductal hyperplasia and a prominent intraduct component in the invasive tumor. Both had axillary lymph node metastases. The significance of the association of breast carcinoma with prolactinoma is discussed. Whereas studies in animals have shown prolactin to be an initiator and promoter of breast carcinoma, studies in humans have been inconclusive. Some studies have shown raised levels of prolactin in patients with breast carcinoma and their daughters, while others have not. The paucity of case reports linking breast carcinoma and prolactinoma may indicate that the association is mere coincidence, but studies evaluating the relationship between breast carcinoma and all forms of hyperprolactinemia need to be conducted before a causal link is dismissed. Prolactin may act as a cofactor with, for example, estrogen or stress, to induce breast carcinoma.

Entities:  

Mesh:

Year:  1997        PMID: 9271027     DOI: 10.1080/00313029700169205

Source DB:  PubMed          Journal:  Pathology        ISSN: 0031-3025            Impact factor:   5.306


  7 in total

Review 1.  A rare case of male breast ductal carcinoma in-situ associated with prolactinoma.

Authors:  Chandike Maithri Mallawaarachchi; Snezana Ivanova; Alice Shorthouse; Sami Shousha; Dudley Sinnett
Journal:  BMJ Case Rep       Date:  2011-08-31

2.  Effect of the preventive-therapeutic administration of melatonin on mammary tumour-bearing animals.

Authors:  M C Saez; C Barriga; J J Garcia; A B Rodríguez; E Ortega
Journal:  Mol Cell Biochem       Date:  2005-01       Impact factor: 3.396

Review 3.  Prolactinoma through the female life cycle.

Authors:  Deirdre Cocks Eschler; Pedram Javanmard; Katherine Cox; Eliza B Geer
Journal:  Endocrine       Date:  2017-11-24       Impact factor: 3.633

Review 4.  The role of prolactin in mammary carcinoma.

Authors:  Charles V Clevenger; Priscilla A Furth; Susan E Hankinson; Linda A Schuler
Journal:  Endocr Rev       Date:  2003-02       Impact factor: 19.871

Review 5.  Prolactin and breast cancer etiology: an epidemiologic perspective.

Authors:  Shelley S Tworoger; Susan E Hankinson
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-02-02       Impact factor: 2.673

6.  Giant prolactinoma, germline BRCA1 mutation, and depression: a case report.

Authors:  Rita Bettencourt-Silva; Joana Queirós; Josué Pereira; Davide Carvalho
Journal:  J Med Case Rep       Date:  2018-12-06

7.  The risk for breast cancer is not evidently increased in women with hyperprolactinemia.

Authors:  O M Dekkers; J A Romijn; A de Boer; J P Vandenbroucke
Journal:  Pituitary       Date:  2010-09       Impact factor: 4.107

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.